Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PCI Biotech Holding ASA ( (DE:4QG) ) just unveiled an announcement.
PCI Biotech Holding ASA has been placed in Oslo Børs’ Recovery Box as of 30 January 2026, a special trading compartment used when circumstances make pricing of a company’s securities particularly uncertain. Securities remain there until those uncertainties are resolved, signaling heightened risk and closer market scrutiny for the company’s shares.
The exchange also maintains a separate Penalty Bench for issuers that fail to comply with listing rules, moving securities back to the normal market once violations are corrected. The classification framework underscores Euronext Oslo Børs’ focus on investor protection and transparency, and highlights the regulatory pressures facing companies like PCI Biotech when their situation or compliance status raises concerns.
More about PCI Biotech Holding ASA
PCI Biotech Holding ASA is a Norway-listed biotechnology company whose shares trade on Euronext Oslo Børs. The company operates in a regulated market environment governed by Oslo Børs rules, which oversee listing conditions, disclosure standards, and trading compartments for issuers facing operational or regulatory uncertainties.
YTD Price Performance: -21.54%
Average Trading Volume: 195,312
Current Market Cap: NOK7.22M
See more insights into 4QG stock on TipRanks’ Stock Analysis page.